BioSpace News Archive

Danimer Scientific, Inc. (NYSE: DNMR) (“Danimer” or the “Company”) chief executive officer Stephen Croskrey will be taking part in a high-level Summit on Biotechnology & Biomanufacturing for the American Bioeconomy, being hosted today by the White House Administration.

Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”), a biotechnology company developing novel therapeutic candidates targeting ferroptosis, an emerging new anti-cancer mechanism resulting in iron-mediated cell death for drug resistant and devastating cancers, will participate in the Fierce Biotech Summit.

Bolstering its commitment to providing researchers with powerful tools to discover more about biology and advance medicine, global genomics solutions provider Integrated DNA Technologies (IDT) is expanding access to its customization options for the Alt-R™ Custom CRISPR gRNA Libraries.

Parexel, a leading global clinical research organization, announced the promotions of Peyton Howell to the newly-created role of Chief Operating and Growth Officer and Amy McKee, MD, to Chief Medical Officer and Global Head, Oncology Center of Excellence.

Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company with a Research & Development (“R&D”) innovation engine that aims to discover, develop, and ultimately deliver impactful medicines to patients, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to SerpinPC, a novel inhibitor of activated protein C (“APC”), for the treatment of hemophilia B.

United Imaging, a global leader in advanced medical imaging and radiotherapy equipment, announced that The Center for Quantitative Cancer Imaging at Huntsman Cancer Institute, part of the University of Utah health care system in Salt Lake City, has installed its first of two United Imaging PET/CT scanners, which brings state-of-the-art molecular imaging technology to the CQCI clinical research lab.

Cambrian BioPharma, a multi-asset longevity biotech, announces its Scientific Advisory Board and appointment of C. David Nicholson, PhD and Frank S. Walsh, PhD to lead.

Celcuity Inc. today announced the appointment of Polly Murphy, D.V.M., Ph.D. to its Board of Directors.

A new report by Dr. Steven R. Feldman, Professor of Dermatology at Wake Forest School of Medicine has confirmed the effectiveness of Perfect Corp.’s AI Skin technology in evaluating skin characteristics in dermatology practice and medical spa settings.

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, announces that it has signed an agreement with Caris Life Sciences® (Caris), a leading molecular science and technology company actively developing and delivering innovative solutions to revolutionize healthcare.